EUVIMEDEUVIMED entdecken
Crossref

Possible new biomarkers to predict the recurrence and ophthalmopathy in patients with graves'

Ayşgeül Merç Çetinkaya, Levent Elmas, Yavuz Dodurga, Güzin Fidan Yaylalı

Pamukkale Medical Journal · 10.07.2026 · 19 (3) · 591-598

DOI: 10.31362/patd.1820006 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pamukkale Medical Journal, online erschienen am 10.07.2026. Verfasst von Ayşgeül Merç Çetinkaya und 3 weiteren Autor:innen. Die Arbeit nennt 13 Literaturangaben. Gefördert von: This work was supported by the Pamukkale University Scientific Research Projects Coordination Unit..

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

Graves' disease (GD) is an antibody-mediated autoimmune thyroid disease characterized by hyperthyroidism and diffuse goiter. This study aimed to investigate the efficiency of novel biomarkers in the follow-up of Graves' disease (GD) by focusing on the expression of selected microRNAs (miRNAs).Materials and methods: Patients who were diagnosed with GD were included in this study. Expression levels of selected miRNAs were measured in both patients with GD (Group 1) and healthy controls (Group 2) by the real-time PCR method. The levels were compared between these two groups. The presence of ophthalmopathy and relapse was assessed and any effect of miRNA expression levels on those clinical parameters was evaluated.

Results

There were 30 patients in each group. There was no significant difference between the groups in terms of the expression levels of selected miRNAs. However, there was a significant difference between the miR-154 expression levels of the patients with and without relapse (p=0.035).

Conclusion

As per these results, miR-154 can be considered a predictor of disease relapse in the setting of GD. Further studies including larger newly diagnosed and untreated GD patient populations are needed to support this hypothesis.

Förderung

  • This work was supported by the Pamukkale University Scientific Research Projects Coordination Unit.

Zitieren

APA

Çetinkaya, A. M., Elmas, L., Dodurga, Y., & Yaylalı, G. F. (2026). Possible new biomarkers to predict the recurrence and ophthalmopathy in patients with graves'. Pamukkale Medical Journal, 19(3), 591-598. https://doi.org/10.31362/patd.1820006

Vancouver

Çetinkaya AM, Elmas L, Dodurga Y, Yaylalı GF. Possible new biomarkers to predict the recurrence and ophthalmopathy in patients with graves'. Pamukkale Medical Journal. 2026;19(3):591-598. doi:10.31362/patd.1820006

BibTeX
@article{etinkaya2026,
  author = {Çetinkaya, Ayşgeül Merç and Elmas, Levent and Dodurga, Yavuz and Yaylalı, Güzin Fidan},
  title = {Possible new biomarkers to predict the recurrence and ophthalmopathy in patients with graves'},
  journal = {Pamukkale Medical Journal},
  year = {2026},
  volume = {19},
  number = {3},
  pages = {591--598},
  doi = {10.31362/patd.1820006}
}
Kostenlos starten →